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N-acetylcysteine (NAC) is an amino acid that contains a cysteine group 
and is currently used widely in various fields of medical research 
especially in cardiology. In this review, potential benefits of NAC in the 
aggregation of platelet and reperfusion injury are evaluated. 
Methods and Results: 
The available evidence was collected by searching Scopus, Pub-Med, 
Medline, Cochrane central register of controlled trials, and Cochrane 
database systematic reviews. Our searching was performed without time 
limitation and only English language articles were included in this review. 
Key words used as search terms included “N-acetylcysteine”, “platelet 
aggregation”, “reperfusion injury”. Over the past decade, several 
investigations were carried out to ascertain reperfusion injury and 
antiplatelet properties of NAC, and in this article the results of 
investigations in both models (human and animal) were addressed in 
details. The results revealed that NAC has an important antiplatelet 
property in animal models while this effect is not very significant in 
human models and needs more investigations. However, its reperfusion 
injury in both models is worth noticing. 
Conclusions: 
Due to the limited data about effectiveness of NAC in both human and 
animal as antiplatelet agent, more investigation is needed to evaluate 
NAC efficacy in platelet aggregation and reperfusion injury especially in 
human studies in the future. 
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